The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition
Year: 2000
Type: article
Study design: Observational Study
Source: Clinical Endocrinology
Institutions: University of Manchester, The Christie Hospital
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: Leydig cell dysfunction, bone mineral density, body composition, procarbazine, cytotoxic chemotherapy, high-dose chemotherapy, hematologic malignancies, testosterone, luteinizing hormone, femoral neck, lumbar spine, bone turnover markers, insulin-like growth factor I, lean body mass, fat mass
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2054988105
